Skip to content

3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine

C19H20FN7O — CID 139331381

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine
SMILESCC(C)n1nc(-c2noc(C3CC3)c2-c2ccn(C)n2)c2c(N)ncc(F)c21
InChIInChI=1S/C19H20FN7O/c1-9(2)27-17-11(20)8-22-19(21)14(17)15(24-27)16-13(12-6-7-26(3)23-12)18(28-25-16)10-4-5-10/h6-10H,4-5H2,1-3H3,(H2,21,22)
InChIKeyCEEFYEHBBBRWNN-UHFFFAOYSA-N
MW381.42 g/mol
LogP3.67
Rot. Bonds4

About 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine

3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine (PubChem CID 139331381) has the molecular formula C19H20FN7O and a molecular weight of 381.42 g/mol. Its IUPAC name is 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine.

Molecular Properties

Compound Name3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine
PubChem CID139331381
Molecular FormulaC19H20FN7O
Molecular Weight381.42 g/mol
Exact Mass381.17
IUPAC Name3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine
SMILESCC(C)n1nc(-c2noc(C3CC3)c2-c2ccn(C)n2)c2c(N)ncc(F)c21
InChIInChI=1S/C19H20FN7O/c1-9(2)27-17-11(20)8-22-19(21)14(17)15(24-27)16-13(12-6-7-26(3)23-12)18(28-25-16)10-4-5-10/h6-10H,4-5H2,1-3H3,(H2,21,22)
InChIKeyCEEFYEHBBBRWNN-UHFFFAOYSA-N
XLogP3.67
TPSA100.58 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500381.42
LogP ≤ 53.67
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine?
The IUPAC name of 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine (CID 139331381) is 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine.
What is the SMILES notation for 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine?
The canonical SMILES for 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine is CC(C)n1nc(-c2noc(C3CC3)c2-c2ccn(C)n2)c2c(N)ncc(F)c21.
What is the InChIKey of 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine?
The InChIKey is CEEFYEHBBBRWNN-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20FN7O/c1-9(2)27-17-11(20)8-22-19(21)14(17)15(24-27)16-13(12-6-7-26(3)23-12)18(28-25-16)10-4-5-10/h6-10H,4-5H2,1-3H3,(H2,21,22).
What are the key properties of 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine?
3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine has a molecular weight of 381.42 g/mol, XLogP of 3.67, 4 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-cyclopropyl-4-(1-methylpyrazol-3-yl)-1,2-oxazol-3-yl]-7-fluoro-1-propan-2-ylpyrazolo[4,5-c]pyridin-4-amine is sourced from PubChem (CID 139331381), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.